EPIX 1.6 (+0%)
CA29668H7085BiotechnologyBiotechnology

ESSA Pharma (EPIX) Stock Highlights

1.6 | +0%
2024-12-21 07:01:03
ESSA Pharma Inc is a pharmaceutical company. The company is in the preclinical stage, focused on the development of small molecule drugs for the treatment of castration-resistant prostate cancer. The company is developing drugs that selectively block the amino-terminal domain of the androgen receptor, potentially overcoming the known AR-dependent resistance mechanisms of CRPC and providing CRPC patients with the potential for increased progression-free and overall survival.

Statistics

Range Today
1.58 1.64
Volume Today 245.7K
Range 1 Year
1.4 11.67
Volume 1 Year 73.86M
Range 3 Year
1.4 14.88
Volume 3 Year 369.67M
Range 10 Year
1.4 245
Volume 10 Year 490.15M

Highlights

Market Capitalization 79.9M (small)
Floating Shares 25.16M
Current Price 1.6
Price To Earnings -2.9
Price To Book 0.62
Earnings Per Share -0.63
Payout Ratio 0%

Performance

Latest 0%
1 Month -6.43%
3 Months -74.96%
6 Months -66.1%
1 Year -75.04%
3 Years -87.67%
5 Years -71.53%
10 Years -98.13%

Benchmarks


Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.